SCHEMBL16167828

SCHEMBL16167828

COc1cc(Br)c(Br)cc1C

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.56
POLB P06746 1/20 0.56
NQO2 P16083 4/20 0.50
MAPT P10636 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
PRKDC P78527 1/20 0.45
LCK P06239 1/20 0.43
FYN P06241 1/20 0.43
ALDH1A1 P00352 1/20 0.42
PRNP P04156 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
TAAR1 Q96RJ0 2/20 0.42
ALOX5 P09917 1/20 0.41
PTGS2 P35354 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.39
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12957756 0.87 NQO2 (0.48) L3MBTL1POLBNQO2MAPTNPSR1
SCHEMBL3297985 0.87 GRIN2D (0.45) L3MBTL1POLBNQO2MAPTNPSR1
SCHEMBL20836401 0.87 MAPT (0.50) L3MBTL1POLBNQO2MAPTNPSR1
SCHEMBL31483694 0.87 MAPT (0.50) L3MBTL1POLBNQO2MAPTNPSR1
SCHEMBL5859293 0.87 TSHR (0.47) L3MBTL1POLBNQO2MAPTNPSR1
SCHEMBL13564409 0.84 NQO2 (0.43) L3MBTL1POLBNQO2MAPTNPSR1
SCHEMBL369991 0.83 POLB (0.67) L3MBTL1POLBMAPTNPSR1PRKDC
SCHEMBL29878552 0.83 POLB (0.67) L3MBTL1POLBMAPTNPSR1PRKDC
SCHEMBL24769695 0.83 NQO2 (0.42) L3MBTL1POLBNQO2MAPTNPSR1
SCHEMBL15031974 0.82 MAPT (0.50) L3MBTL1POLBNQO2MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2803659-B1 Method for synthesising 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carbonitrile and use for synthesising ivabradine and the added salts thereof with a pharmaceutically acceptable acid SERVIER LAB (FR) 2017-01-04 EP disclosed
US-8859763-B1 Process for the synthesis of 3,4-dimethoxybicyclo[4.2.0]OCTA-1,3,5-triene-7-carbonitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid LES LABORATOIRES SERVIER (FR) 2014-10-14 US disclosed